Provided by Tiger Trade Technology Pte. Ltd.

Legend Biotech

18.45
-0.6651-3.48%
Volume:888.03K
Turnover:16.32M
Market Cap:3.59B
PE:-36.85
High:18.91
Open:18.91
Low:18.09
Close:19.12
52wk High:37.50
52wk Low:16.24
Shares:194.49M
Float Shares:193.53M
Volume Ratio:0.84
T/O Rate:0.46%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5008
EPS(LYR):-1.6200
ROE:-8.08%
ROA:-1.92%
PB:2.92
PE(LYR):-11.39

Loading ...

Legend Biotech falls -12.5%

TIPRANKS
·
Jul 27

Legend Biotech price target lowered to $59 from $63 at RBC Capital

TIPRANKS
·
Jul 27

RBC Cuts Price Target on Legend Biotech to $59 From $63, Keeps Outperform Rating

MT Newswires Live
·
Jul 27

Legend Biotech Shares Down 3.7% Premarket; Ying Huang Steps Down as CEO and Board Member, Alan Bash Appointed Interim CEO

THOMSON REUTERS
·
Jul 27

Legend Biotech Names Alan Bash Interim CEO After Ying Huang Resigns

Reuters
·
Jul 27

Legend Biotech Corp - Ying Huang Steps Down as CEO and Board Member; to Remain as Advisor Through August

THOMSON REUTERS
·
Jul 27

Legend Biotech Corp - Alan Bash Appointed Interim CEO

THOMSON REUTERS
·
Jul 27

Legend Biotech Corp - Board Initiates Search for Permanent CEO Successor

THOMSON REUTERS
·
Jul 27

Legend Biotech Announces CEO Transition

THOMSON REUTERS
·
Jul 27

Legend Biotech Shares Fall After UBS Downgrade

MT Newswires Live
·
Jul 25

Legend Biotech Cut to Neutral from Buy by UBS

Dow Jones
·
Jul 24

UBS Downgrades Legend Biotech to Neutral From Buy, Adjusts Price Target to $28 From $49

MT Newswires Live
·
Jul 24

Legend Biotech downgraded to Neutral from Buy at UBS

TIPRANKS
·
Jul 24

Analysts Offer Insights on Healthcare Companies: Medicinova (MNOV), Legend Biotech (LEGN) and AngioDynamics (ANGO)

TIPRANKS
·
Jul 16

Genscript Highlights Strong CARVYKTI Sales via Legend Biotech, Urges Investor Caution

TIPRANKS
·
Jul 15

Legend Biotech: Carvykti® Generated About $657 Million in Net Trade Sales During Qtr Ended June 30, 2026

THOMSON REUTERS
·
Jul 15

Barclays Sticks to Its Buy Rating for Legend Biotech (LEGN)

TIPRANKS
·
Jul 14

Legend Biotech Price Target Announced at $35.00/share by JP Morgan

Dow Jones
·
Jul 13

Legend Biotech is Maintained at Outperform by RBC Capital

Dow Jones
·
Jul 08

RBC Capital Adjusts Legend Biotech Price Target to $63 From $64, Maintains Outperform Rating

MT Newswires Live
·
Jul 07